The early detection of liver cirrhosis (LC) is crucial due to its high morbidity and mortality in advanced stages. Reliable, non-invasive diagnostic tools are essential for timely intervention. Exhaled human breath, reflecting metabolic changes, offers significant potential for disease diagnosis. This paper focuses on the emerging role of sensor array-based volatile organic compounds (VOCs) analysis of exhaled breath, particularly using electronic nose (e-nose) technology to differentiate LC patients from healthy controls (HCs). This study included 55 participants: 27 LC patients and 28 HCs. Sensor’s measurement data were analyzed using machine learning techniques, such as principal component analysis (PCA), discriminant function analysis (DFA), and support vector machines (SVMs) that were utilized to uncover meaningful patterns and facilitate accurate classification of sensor-derived information. The diagnostic accuracy was thoroughly assessed through receiver operating characteristic (ROC) curve analysis, with specific emphasis on assessing sensitivity and specificity metrics. The e-nose effectively distinguished LC from HC, with PCA explaining 92.50% variance and SVMs achieving 100% classification accuracy. This study demonstrates the significant potential of e-nose technology towards VOCs analysis in exhaled breath, as a valuable tool for LC diagnosis. It also explores feature extraction methods and suitable algorithms for effectively distinguishing between LC patients and controls. This research provides a foundation for advancing breath-based diagnostic technologies for early detection and monitoring of liver cirrhosis.
War et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: